rs80338899
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000137.4(FAH):c.786G>A(p.Trp262*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000137.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- tyrosinemia type IInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine, G2P, Orphanet, Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FAH | NM_000137.4 | c.786G>A | p.Trp262* | stop_gained | Exon 9 of 14 | ENST00000561421.6 | NP_000128.1 | |
| FAH | NM_001374377.1 | c.786G>A | p.Trp262* | stop_gained | Exon 10 of 15 | NP_001361306.1 | ||
| FAH | NM_001374380.1 | c.786G>A | p.Trp262* | stop_gained | Exon 10 of 15 | NP_001361309.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152210Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000795 AC: 20AN: 251482 AF XY: 0.0000662 show subpopulations
GnomAD4 exome AF: 0.0000581 AC: 85AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.0000578 AC XY: 42AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Tyrosinemia type I Pathogenic:6Other:1
- -
- -
This sequence change creates a premature translational stop signal (p.Trp262*) in the FAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAH are known to be pathogenic (PMID: 9101289, 9633815). This variant is present in population databases (rs80338899, gnomAD 0.07%). This premature translational stop signal has been observed in individuals with tyrosinemia type I in Scandinavia (PMID: 7942842, 8162054, 8829657). ClinVar contains an entry for this variant (Variation ID: 11873). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Finnish-specific pathogenic variant resulting from founder effect or genetic drift [Angileri et al 2015]. -
NM_000137.2(FAH):c.786G>A(W262*) is classified as pathogenic in the context of type I tyrosinemia. Sources cited for classification include the following: PMID 8723698, 8162054, 15465000, 7942842, 15638932 and 8829657. Classification of NM_000137.2(FAH):c.786G>A(W262*) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at